Latest papers

Dynamic deconstructive psychotherapy versus optimized community care for borderline personality disorder co-occurring with alcohol use disorders: a 30-month follow-up.

Dual environments for dual disorders.

Marijuana use and panic psychopathology among a representative sample of adults.

Patients with dual diagnoses or substance use disorders only: 12-step group participation and 1-year outcomes.

Substance misuse and mental health.

Research with the doubly vulnerable population of individuals who abuse alcohol: an ethical dilemma.

Mood stabilizers in the treatment of substance use disorders.

Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment.

Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders.

[Pathological gambling and psychiatric patients].

A multicultural approach to HIV prevention within a residential chemical dependency treatment program: the Positive Steps Program.

Reasons for illicit drug use in people with schizophrenia: Qualitative study.

GPRA and the development of performance measures.

Patients with substance use and personality disorders: a comparison of patient characteristics, treatment process, and outcomes in Swiss and U.S. substance use disorder programs.

Dual diagnosis competency among addiction treatment staff: Training levels, training needs and the link to retention.

The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.

A university-agency mental health research collaboration: a case example.

Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia.

Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.

Gender differences in social support and depression among injection drug users in Houston, Texas.